Anzeige
Mehr »
Donnerstag, 11.09.2025 - Börsentäglich über 12.000 News
Diese Aktie sichert sich Exklusiv-Partnerschaft mit Babcock für Ukraine-Defence - Neubewertung voraus?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PQTV | ISIN: SE0011178458 | Ticker-Symbol: KN0
Frankfurt
10.09.25 | 16:43
0,077 Euro
0,00 % 0,000
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
DICOT PHARMA AB Chart 1 Jahr
5-Tage-Chart
DICOT PHARMA AB 5-Tage-Chart

Aktuelle News zur DICOT PHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
27.08.Dicot Pharma AB: Dicot Pharma included in global stock index98Uppsala, Sweden, August 27, 2025. As of today, the Swedish, erectile dysfunction drug developer Dicot Pharma has been incorporated into the MSCI Global Micro Cap Index, managed by MSCI, the world's...
► Artikel lesen
20.08.Dicot Pharma AB: Dicot Pharma's Phase 2a study completed - results within three months129Uppsala, Sweden, August 20, 2025. Today, potency drug developer Dicot Pharma announces that the clinical part of its phase 2a study has been completed, as the final participant now has completed the...
► Artikel lesen
12.08.Dicot Pharma AB: Dicot Pharma presents interim report Q2 2025147Uppsala, Sweden, August 12, 2025. Dicot Pharma AB publishes its interim report for the second quarter of 2025. The report is available as an attached document and on www.dicotpharma.com. The company's...
► Artikel lesen
25.06.DICOT PHARMA AB: All participants in Dicot Pharma's phase 2a study are dosed3
28.05.DICOT PHARMA AB: Dicot Pharma's new findings on mechanism of action: "affects the nerves controlling penile erection"2
DICOT PHARMA Aktie jetzt für 0€ handeln
06.05.DICOT PHARMA AB: Report from the Annual General Meeting of Dicot Pharma2
29.04.Dicot Pharma AB: Dicot Pharma presents interim report Q1 2025201Uppsala, Sweden, April 29, 2025. Dicot Pharma AB publishes its interim report for the first quarter of 2025. The report is available as an attached document and on www.dicotpharma.com. The company's...
► Artikel lesen
17.04.DICOT PHARMA AB: Dicot Pharma publishes its annual report for 20242
03.04.DICOT PHARMA AB: Summon to Annual General Meeting in Dicot Pharma May 6 at 17.001
02.04.DICOT PHARMA AB: Dicot Pharma's TO 6 subscribed at 96% and provides the company SEK 43.8 million2
26.03.DICOT PHARMA AB: Last day of trading in Dicot Pharma TO 6 warrants tomorrow, March 274
17.03.DICOT PHARMA AB: Dicot Pharma invites to a Q&A session on TO 61
17.03.DICOT PHARMA AB: Exercise Period for Warrants TO6 in Dicot Pharma Begins Today1
13.02.Dicot Pharma AB: Dicot Pharma AB Year-End Report 2024148Uppsala, Sweden, February 13, 2024. Dicot Pharma publishes its year-end report for the financial year 2024 and for the fourth quarter. The report is available as an attached document and on www.dicotpharma.com....
► Artikel lesen
20.11.24Dicot Pharma AB: First participants dosed in Dicot Pharma's Phase 2a clinical study219Uppsala, Sweden, November 20, 2024. The first participants in Dicot Pharma's Phase 2a clinical study have now been dosed. The company's drug candidate LIB-01 is being developed as a new first-line treatment...
► Artikel lesen
06.11.24Nasdaq Stockholm AB: Listing of Dicot Pharma AB on Nasdaq First North Growth Market Sweden357On request of Dicot Pharma AB, company registration number 559006-3490, Nasdaq Stockholm AB has admitted the company's shares and equity rights to trading on Nasdaq First North Growth Market Sweden...
► Artikel lesen
16 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1